These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8681669)

  • 21. Effects of high-dose ipratropium bromide and oral aminophylline on spirometry and exercise tolerance in COPD.
    Shivaram U; Cash ME; Mateo F; Shim C
    Respir Med; 1997 Jul; 91(6):327-34. PubMed ID: 9282234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of short-acting bronchodilators added to maintenance tiotropium therapy.
    Kerstjens HA; Bantje TA; Luursema PB; Sinninghe Damste HE; de Jong JW; Lee A; Wijker SP; Cornelissen PJ
    Chest; 2007 Nov; 132(5):1493-9. PubMed ID: 17890476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
    Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T
    Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A dose-response and duration of action assessment of a combined preparation of fenoterol and ipratropium bromide (Duovent).
    Packe GE; Archer PS; Cayton RM
    Postgrad Med J; 1984; 60 Suppl 1():18-22. PubMed ID: 6233546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nebulized ipratropium bromide in the treatment of acute asthma.
    Bryant DH
    Chest; 1985 Jul; 88(1):24-9. PubMed ID: 2861067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
    Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
    Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation.
    Morrison JF; Jones PC; Muers MF
    Eur Respir J; 1992 Apr; 5(4):424-9. PubMed ID: 1532940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ipratropium bromide and fenoterol by aerosolized solution.
    Jenkins CR; Chow CM; Fisher BL; Marlin GE
    Br J Clin Pharmacol; 1982 Jul; 14(1):113-5. PubMed ID: 6213250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of nebulized levalbuterol in stable COPD.
    Datta D; Vitale A; Lahiri B; ZuWallack R
    Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of inhaled ipratropium bromide, fenoterol and their combination in COPD patients.
    Charoenpan P; Kiatboonsri S; Uswanopakhun P; Vongvivat K; Sulaimanee P
    J Med Assoc Thai; 1990 Feb; 73(2):91-5. PubMed ID: 2141057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventilation-perfusion distributions and central hemodynamics in chronic obstructive pulmonary disease. Effects of terbutaline administration.
    Ringsted CV; Eliasen K; Andersen JB; Heslet L; Qvist J
    Chest; 1989 Nov; 96(5):976-83. PubMed ID: 2805868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bronchodilator treatment of COPD].
    Naberan K
    Aten Primaria; 1998 Feb; 21(2):109-13. PubMed ID: 9608136
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute controlled study of the dose-response relationship of fenoterol, ipratropium bromide and their combination.
    Serra C; Giacopelli A; Luciani G
    Respiration; 1986; 50 Suppl 2():144-7. PubMed ID: 2951793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of fenoterol on ventilatory response to hypercapnia and hypoxia in patients with chronic obstructive pulmonary disease.
    Suzuki S; Watanuki Y; Yoshiike Y; Okubo T
    Thorax; 1997 Feb; 52(2):125-9. PubMed ID: 9059471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversibility tests in chronic obstructive airways disease: their predictive value with reference to benefit from domiciliary nebuliser therapy.
    Teale C; Morrison JF; Jones PC; Muers MF
    Respir Med; 1991 Jul; 85(4):281-4. PubMed ID: 1835110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the intensity and duration of the bronchodilatory action of fenoterol-ipratropium bromide in combination compared with terbutaline and placebo in patients with chronic obstructive lung disease.
    Longhini E; Bozzoni M; Mastropasqua B; Marazzini L
    Respiration; 1986; 50 Suppl 2():169-72. PubMed ID: 2951799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation.
    Díaz O; Barberà JA; Marrades R; Chung KF; Roca J; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1997 Jul; 156(1):17-22. PubMed ID: 9230720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD.
    Dorinsky PM; Reisner C; Ferguson GT; Menjoge SS; Serby CW; Witek TJ
    Chest; 1999 Apr; 115(4):966-71. PubMed ID: 10208193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Basic medication of chronic obstructive lung disease with berodual].
    Melent'eva EM
    Klin Med (Mosk); 1999; 77(7):47-8. PubMed ID: 10483166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.